Wiadomosci lekarskie (Warsaw, Poland : 1960) · 2025
Exploring the Association of Campylobacter jejuni with inflammatory bowel diseases: insight from a clinical study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kadhim Nisreen Jawad, ALzamili Fadhl, Hnewa Riadh, Al-Shamaa Ali Sameer, Kadhim Haider Sabah, Al-Mussawi Kawther A M
Аннотация
OBJECTIVE: Aim: To demonstrate a possible association between Campylobacter jejuni and inflammatory bowel disease Iraqi patients.
PATIENTS AND METHODS: Materials and methods: The study involved two groups. The inflammatory bowel disease patient group consisted of 90 participants. This group was further classified into two subgroups: Crohn's disease (n) and Ulcerative colitis (n). The control group consisted of 90 healthy participants who had no history of inflammatory bowel disease. Age and gender distributions in inflammatory bowel disease patient and control groups were computed. The association between inflammatory bowel disease and C. jejuni was determined by identifying the bacterial infection using various detection methods, including culturing, biochemical tests and real-time PCR (Polymerase chain reaction). The association was further assessed by comparing the symptoms of IBD patients and C. jejuni positive samples.
RESULTS: Results: Finding of the conventional identification showed 5% prevalence of C. jejuni among inflammatory bowel disease patients whereas the real-time Polymerase chain reaction. Results showed significantly higher prevalence. Based on real-time Polymerase chain reaction. Results, a significant association was found between C. jejuni infection with inflammatory bowel disease and Crohn's disease patients (P-value≤0.001).
CONCLUSION: Conclusions: No significant differences observed in detection of inflammatory bowel disease and Crohn's disease using conventional and molecular methods. The study provides valuable insights into a possible association between C. jejuni and inflammatory bowel disease.
PATIENTS AND METHODS: Materials and methods: The study involved two groups. The inflammatory bowel disease patient group consisted of 90 participants. This group was further classified into two subgroups: Crohn's disease (n) and Ulcerative colitis (n). The control group consisted of 90 healthy participants who had no history of inflammatory bowel disease. Age and gender distributions in inflammatory bowel disease patient and control groups were computed. The association between inflammatory bowel disease and C. jejuni was determined by identifying the bacterial infection using various detection methods, including culturing, biochemical tests and real-time PCR (Polymerase chain reaction). The association was further assessed by comparing the symptoms of IBD patients and C. jejuni positive samples.
RESULTS: Results: Finding of the conventional identification showed 5% prevalence of C. jejuni among inflammatory bowel disease patients whereas the real-time Polymerase chain reaction. Results showed significantly higher prevalence. Based on real-time Polymerase chain reaction. Results, a significant association was found between C. jejuni infection with inflammatory bowel disease and Crohn's disease patients (P-value≤0.001).
CONCLUSION: Conclusions: No significant differences observed in detection of inflammatory bowel disease and Crohn's disease using conventional and molecular methods. The study provides valuable insights into a possible association between C. jejuni and inflammatory bowel disease.